Display Settings:

Format

Send to:

Choose Destination
    Med Hypotheses. 2003 Aug;61(2):206-9.

    Exploiting intracellular iron and iron-rich compounds to effect tumor cell lysis.

    Source

    Stem Cell Therapies, San Clemente, CA 92673, USA. dragpayne@yahoo.com

    Abstract

    The regimen outlined in this brief paper focuses on therapeutically utilizing iron and iron compounds in transferrin receptor-rich tumor cells in ways that inhibit and lyse same.

    PMID:
    12888304
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk